Patent ID: 7858602

Claim:
A method for the treatment of condition of aging associated with a decreased presence of one or more carbonic anhydrase enzymes, which method comprises the following steps: (a) identifying a subject who is exhibiting signs of Alzheimer's disease; (b) measuring and identifying which one or more of carbonic anhydrase enzymes I (CA-I), II (CA-II), III (CA-III), IV (CA-IV), V (CA-V), VI (CA-VI) and VII (CA-VII) are present at decreased levels in the blood, brain cells, or cerebrospinal fluid of said subject; (c) administering to a subject who has been identified with decreased levels of CA-II in step (b) an effective, non-toxic amount of vitamin D 3 to increase the levels of CA-II; and (d) further administering to the subject an effective, non-toxic amount of an active ingredient selected from the group consisting of zinc, indomethacin, phorbol myristate acetate and cysteamine to increase the levels of other carbonic anhydrase enzymes; wherein steps (c) and (d) are carried out for an extended period of time in the range of six months to five years.